Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06138561

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:24.808696+00:00

Published At

2026-02-17T00:00:00+00:00

Record Updated At

2026-02-17

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Bladder Cancer", "Metastatic Bladder Cancer", "Unresectable Bladder Carcinoma", "Urothelial Carcinoma"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-02-17"

protocolSection.identificationModule.nctId

"NCT06138561"

protocolSection.identificationModule.officialTitle

"Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Bladder Cancer (protocolSection.conditionsModule.conditions)
• Metastatic Bladder Cancer (protocolSection.conditionsModule.conditions)
• Unresectable Bladder Carcinoma (protocolSection.conditionsModule.conditions)
• Urothelial Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.